March 7, 2016

AbbVie Inc (ABBV) Downgraded to Buy


AbbVie Inc (NASDAQ:ABBV) was downgraded by equities researchers at Goldman Sachs from a “conviction-buy” rating to a “buy” rating in a research note issued to investors on Monday, The Fly reports.
In other news, SVP Timothy J. Richmond sold 12,866 shares of AbbVie stock in a transaction that occurred on Tuesday, March 1st. The shares were sold at an average price of $55.05, for a total transaction of $708,273.30. Following the completion of the sale, the senior vice president now directly owns 79,064 shares in the company, valued at approximately $4,352,473.20. The transaction was disclosed in a legal filing with the SEC,

Source: The Hilltop News.